138 related articles for article (PubMed ID: 20304055)
41. Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D3 from pagetic bone marrow cells.
Ishizuka S; Kurihara N; Miura D; Takenouchi K; Cornish J; Cundy T; Reddy SV; Roodman GD
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):331-4. PubMed ID: 15225795
[TBL] [Abstract][Full Text] [Related]
42. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the cytokine pattern of porcine bone marrow-derived cells treated with 1alpha,25(OH)D.
Sipos W; Duvigneau JC; Schmoll F; Exel B; Hofbauer G; Baravalle G; Hartl RT; Dobretsberger M; Pietschmann P
J Vet Med A Physiol Pathol Clin Med; 2005 Oct; 52(8):382-7. PubMed ID: 16176565
[TBL] [Abstract][Full Text] [Related]
44. [RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling].
Mizoguchi T
Clin Calcium; 2011 Aug; 21(8):1187-92. PubMed ID: 21814024
[TBL] [Abstract][Full Text] [Related]
45. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
46. 1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease.
Menaa C; Barsony J; Reddy SV; Cornish J; Cundy T; Roodman GD
J Bone Miner Res; 2000 Feb; 15(2):228-36. PubMed ID: 10703924
[TBL] [Abstract][Full Text] [Related]
47. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
48. Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
O'Brien EA; Williams JH; Marshall MJ
Biochem Biophys Res Commun; 2000 Aug; 274(2):281-90. PubMed ID: 10913332
[TBL] [Abstract][Full Text] [Related]
49. Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor.
Zanello LP; Norman AW
Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1589-94. PubMed ID: 14757825
[TBL] [Abstract][Full Text] [Related]
50. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
[TBL] [Abstract][Full Text] [Related]
51. Cloning of a functional 25-hydroxyvitamin D-1α-hydroxylase in zebrafish (Danio rerio).
Chun RF; Blatter E; Elliott S; Fitz-Gibbon S; Rieger S; Sagasti A; Adams JS; Hewison M
Cell Biochem Funct; 2014 Dec; 32(8):675-82. PubMed ID: 25290078
[TBL] [Abstract][Full Text] [Related]
52. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts.
Bi Y; Nielsen KL; Kilts TM; Yoon A; A Karsdal M; Wimer HF; Greenfield EM; Heegaard AM; Young MF
Bone; 2006 Jun; 38(6):778-86. PubMed ID: 16364709
[TBL] [Abstract][Full Text] [Related]
53. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
[TBL] [Abstract][Full Text] [Related]
54. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
55. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
56. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D metabolism and signaling in the immune system.
White JH
Rev Endocr Metab Disord; 2012 Mar; 13(1):21-9. PubMed ID: 21845364
[TBL] [Abstract][Full Text] [Related]
58. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism.
Edfeldt K; Liu PT; Chun R; Fabri M; Schenk M; Wheelwright M; Keegan C; Krutzik SR; Adams JS; Hewison M; Modlin RL
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22593-8. PubMed ID: 21149724
[TBL] [Abstract][Full Text] [Related]
59. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression.
Sakai S; Takaishi H; Matsuzaki K; Kaneko H; Furukawa M; Miyauchi Y; Shiraishi A; Saito K; Tanaka A; Taniguchi T; Suda T; Miyamoto T; Toyama Y
J Bone Miner Metab; 2009; 27(6):643-52. PubMed ID: 19449179
[TBL] [Abstract][Full Text] [Related]
60. Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts.
Anderson PH; Iida S; Tyson JH; Turner AG; Morris HA
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):71-5. PubMed ID: 20236619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
